SIMID First European Provider of Online Full Text Publications

SIMID International B.V.SIMID is the first in Europe to use a single centralized databank to bring scientific-medical full-text publications within easy reach. Through S.M.I.L.E. (Scientific Medical Information Library Europe), medical professionals can search for and download original publications and reviews online, from prominent international peer-reviewed medical scientific journals. Currently, the database contains more than 1000 journals from 28 internationally renowned publishers. S.M.I.L.E. is accessible through www.simid.org and is made possible in part by financial institutions and companies working in the healthcare industry, such as health insurance providers and the pharmaceutical industry.

Investment by the Health Innovation Fund
Recently the Health Innovation Fund I BV has joined SIMID as an investor. This fund is financed from Achmea, OPG, ABN/AMRO and TechnoPartner (the Dutch Ministry of Economic Affairs). "We are proud that this investor has provided us the opportunity to expand our unique product further. By informing medical professionals in Europe about the latest developments within their field, our clients can help them diagnose and treat patients more adequately," comments Boudewijn Gruwel, Director of Marketing & Sales of SIMID.

How does S.M.I.L.E. work?
The medical professional has a customized subscription allowing him free access to the information in S.M.I.L.E. This customized subscription is made possible in part by companies working in the healthcare industry, or financial institutions. "The subscriptions give companies the possibility to provide medical professionals access to the most recent and relevant scientific information," states Boudewijn Gruwel.

S.M.I.L.E. lets users read the latest publications, covering 43 different themes, such as oncology, surgery, cardiology, etc. Users can compile a personal profile and receive automatic alerts when relevant articles become available. The database can also be searched using individual keywords. S.M.I.L.E. is updated daily. The publications containing the listed titles are archived from 2000 on, and all articles can be downloaded as PDF files.

Who is S.M.I.L.E.'s target audience?
The S.M.I.L.E. online database is geared toward health professionals. These might be specialists or general practitioners, but might also be dentists, nurses, or physiotherapists.

About SIMID International B.V.
SIMID stands for the Scientific Institute for Medical Information and Documentation. The goal of SIMID is to provide access to scientific-medical information for health professionals by applying the one-stop-shopping principle. Offering complete publications on a single website creates a unique niche in services to medical professionals and the international healthcare-related industry. Through cooperation with international scientific publishers and the online database S.M.I.L.E., SIMID is the first and only company in Europe able to offer this service to medical professionals. SIMID has branches in the Netherlands and Switzerland. More information can be found at www.simid.org.

About the Health Innovation Fund I BV
The Health Innovation Fund I BV is a venture capital fund established in 2007. It focuses on innovative entrepreneurs providing technological, modernizing solutions and business models for the healthcare industry. Shareholders in this fund are ABN/AMRO, Achmea and OPG. The Health Innovation Fund I BV is administered by Residex, which uses specialized investment funds to offer opportunities to promising and ambitious players in the healthcare sector. More information is available at www.residex.nl.

Most Popular Now

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...